Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

Lior mor

355 POSTS

Exclusive articles:

SKN | GraniteShares YieldBOOST TSM ETF: Income-Focused Strategy Targets Tech Exposure in Market Debut

GraniteShares is preparing to launch its YieldBOOST TSM ETF, aiming to raise approximately $8 million US as it brings a yield-enhanced strategy tied to...

SKN | SuperCom Earnings Preview: Can SPCB Sustain Momentum Ahead of Results?

A Niche Security Player Approaches a Key Test SuperCom Ltd. (NASDAQ: SPCB) is heading into its April 14, 2026 earnings release with a mix of...

SKN | Alamar Biosciences Sets Terms for $150 Million IPO in Protein Biomarker Detection Market

Alamar Biosciences, a developer of next-generation protein biomarker detection platforms, has set terms for a $150 million IPO as it prepares for a Nasdaq...

SKN | Abony Acquisition Corp. I Class A Ordinary Share: SPAC IPO Targets Selective Growth Deals in Cooling Market

Abony Acquisition Corp. I is preparing to enter the public markets through an initial public offering of Class A ordinary shares, targeting approximately $8...

SKN | Astera Labs Surges on AI Momentum: Can ALAB Sustain Its Rapid Climb?

Astera Labs, Inc. (NASDAQ: ALAB) has quickly emerged as one of the more compelling names in the semiconductor space, with its stock recently climbing...

Breaking

SKN | Geothermal Developer Fervo Energy Files for Estimated $250 Million IPO

Fervo Energy, a next-generation geothermal energy developer, has filed...

SKN | Mobia Medical Files for $100M IPO as Neurostimulation Therapy Targets $30B Stroke Market

FDA-Approved Device Positions Company in High-Value Neurorehabilitation Segment Mobia Medical...

SKN | Amatuhi Holdings Raises IPO Range as Investor Demand Lifts Expected Proceeds by 60%

Revised Pricing Signals Stronger Market Interest Ahead of Nasdaq...

SKN | Alamar Biosciences Prices Upsized IPO at $17, the High End of the Range

Alamar Biosciences has priced its upsized initial public offering...
spot_imgspot_img